Membranoproliferative Glomerulonephritis und C3‑Glomerulopathie

Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy

(2018) Rupali S. Avasare et al.   Clinical Journal of the American Society of Nephrology

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy

(2018) Marina Noris et al.   PEDIATRIC NEPHROLOGY

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN

(2017) Paraskevas Iatropoulos et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

(2017) Maria-Chiara Marinozzi et al.   KIDNEY INTERNATIONAL

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

(2017) Timothy H.J. Goodship et al.   KIDNEY INTERNATIONAL

Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies

(2017) Michael Rudnicki   Biomed Research International

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome

(2016) Paraskevas Iatropoulos et al.   MOLECULAR IMMUNOLOGY

New milestones ahead in complement-targeted therapy

(2016) Daniel Ricklin et al.   SEMINARS IN IMMUNOLOGY

Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy

(2015) Philippe Giaime et al.   CLINICAL NEPHROLOGY

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis

(2015) Cristina Rabasco et al.   KIDNEY INTERNATIONAL

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome

(2014) Mihály Józsi et al.   IMMUNOLOGY LETTERS

Histopathology of MPGN and C3 glomerulopathies

(2014) H. Terence Cook et al.   Nature Reviews Nephrology

Rituximab fails where eculizumab restores renal function in C3nef-related DDD

(2014) Caroline Rousset-Rouvière et al.   PEDIATRIC NEPHROLOGY

Treatment of C3 Glomerulopathy with Complement Blockers

(2014) Francesco Emma et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation

(2013) Agustín Tortajada et al.   JOURNAL OF CLINICAL INVESTIGATION

C3 glomerulopathy: consensus report

(2013) Matthew C. Pickering et al.   KIDNEY INTERNATIONAL

Toward a working definition of C3 glomerulopathy by immunofluorescence

(2013) Jean Hou et al.   KIDNEY INTERNATIONAL

Complement factor H related proteins (CFHRs)

(2013) Christine Skerka et al.   MOLECULAR IMMUNOLOGY

The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment

(2012) A. M. Risitano et al.   BLOOD

Combination of Factor H Mutation and Properdin Deficiency Causes Severe C3 Glomerulonephritis

(2012) A. M. Lesher et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies

(2012) Julien Zuber et al.   Nature Reviews Nephrology

C3 glomerulopathy: a new classification

(2010) Fadi Fakhouri et al.   Nature Reviews Nephrology

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway

(2009) Sanjeev Sethi et al.   KIDNEY INTERNATIONAL